Selected Grants
iPediHeart: Interdisciplinary Research Training Program for Pediatric Heart Disease
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2025 - 2030Unified Program for Therapeutics in Children
Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 2025 - 2030CORD-CHD: Clamp OR Delay among neonates with Congenital Heart Disease
ResearchPrincipal Investigator · Awarded by Research Institute at Nationwide Children's Hospital · 2024 - 2030A PHASE 2/3 MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED AND OPEN-LABEL EXTENSION TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF AFICAMTEN IN A PEDIATRIC POPULATION WITH SYMPTOMATIC OBSTRUC
Clinical TrialPrincipal Investigator · Awarded by Cytokinetics, Inc. · 2025 - 2028Stimulating Access to Research in Residency (StARR) - NHLBI
Inst. Training Prgm or CMEPreceptor · Awarded by National Heart, Lung, and Blood Institute · 2018 - 2028Influences Of Social Determinants Of Health And Parental Participation In Hospital Care On Development Of Parenting Confidence Among Parents Of Children With A Congenital Heart Defect
FellowshipCollaborator · Awarded by National Institutes of Health · 2024 - 2026TOMORROW: pediaTric use Of Macitentan tO delay disease pRogRessiOn in PAH Worldwide A multicenter, open-label, randomized, event-driven study to assess efficacy, safety and pharmacokinetics of macitentan
Clinical TrialPrincipal Investigator · Awarded by Actelion Pharmaceuticals Ltd. · 2017 - 2026Partial Heart Transplant Registry.
ResearchCo Investigator · Awarded by The Brett Boyer Foundation · 2025 - 2026The North Carolina Congenital Heart Disease Surveillance Network
Public ServiceCo Investigator · Awarded by Centers for Disease Control and Prevention · 2019 - 2025Fontan Udenafil Exercise Longitudinal Assessment Trial
ResearchPrincipal Investigator · Awarded by New England Research Institutes, Inc. · 2017 - 2024Fontan Udenafil Exercise Longitudinal Assessment Trial-OLE
ResearchPrincipal Investigator · Awarded by New England Research Institutes, Inc. · 2017 - 2024CORD-CHD: Clamp OR Delay among neonates with Congenital Heart Disease
ResearchPrincipal Investigator · Awarded by Nationwide Children's Hospital · 2023 - 2024Bridging the Gap to Enhance Clinical Research Program (BIGGER)
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2016 - 2023Global Pediatric Clinical Trials Network
ResearchCo Investigator · Awarded by Food and Drug Administration · 2017 - 2023PTN 2.0- TO#4/Option 3 Data Closeout and Dissemination
ResearchInvestigator · Awarded by National Institute for Child Health & Human Develo · 2021 - 2022Leveraging registry resources for efficient and cost effective clinical trials
Clinical TrialCo Investigator · Awarded by National Institutes of Health · 2016 - 2022Steriods to Reduce Systemic inflammation after neonatal hart Surgery
Clinical TrialPrincipal Investigator · Awarded by National Institutes of Health · 2016 - 2022A Prospective, Open -Label Active -Controlled study to Evaluate the Pharmacokinetics Pharmacodynamics, Saftey and Efficacy of Rivaroxaban for Thromboprophylaxis in Pediatric Subjects 2 to 8 Years of Age after the Fontan procedure
ResearchPrincipal Investigator · Awarded by Janssen Research & Development, LLC · 2016 - 2021UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program
Inst. Training Prgm or CMEMentor · Awarded by University of North Carolina - Chapel Hill · 2020 - 2021Evaluating post-op AKI criteria in infants with CHD and the protective effects of acetaminophen
ResearchPrincipal Investigator · Awarded by Thrasher Research Fund · 2019 - 2021Understanding Quality and Costs in Congenital Heart Surgery
ResearchCo Investigator · Awarded by Society of Thoracic Surgeons · 2014 - 2021North Carolina Congenital Heart Defects Surveillance Network
ResearchCo Investigator · Awarded by Centers for Disease Control and Prevention · 2015 - 2020The Congenital Heart Technical Skill Study: Improving Outcomes for Infants and Children with Congenital Heart Disease
ResearchPrincipal Investigator · Awarded by Society of Thoracic Surgeons · 2017 - 2019Duke CTSA (KL2)
ResearchScholar · Awarded by National Institutes of Health · 2013 - 2018Safety, Pharmacokinetics (PK) and Hemodynamic Effects of Ambrisentan in Children with Single Ventricle Heart Defects.
FellowshipPrincipal Investigator · Awarded by Gilead Sciences, Inc. · 2015 - 2018Evaluation of endothelial function in single ventricle patients receiving Ambrisentan after surgery.
ResearchCo-Mentor · Awarded by Thrasher Research Fund · 2015 - 2017Institutional Training Grant in Pediatric Cardiology
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2009 - 2015PHN Scholar's grant
ResearchPrincipal Investigator · Awarded by Emory University · 2013 - 2014External Relationships
- Cytokinetics, Inc.
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.